Home
>
National Drug Code (NDC)
>
FLUARIX QUADRIVALENT
FLUARIX QUADRIVALENT - 58160-900-52 - (influenza virus vaccine)
Drug Information of FLUARIX QUADRIVALENT
| Product NDC: | 58160-900 |
| Proprietary Name: | FLUARIX QUADRIVALENT |
| Non Proprietary Name: | influenza virus vaccine |
| Active Ingredient(s): | 15; 15; 15; 15 ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL & nbsp; influenza virus vaccine |
| Administration Route(s): | INTRAMUSCULAR |
| Dosage Form(s): | SUSPENSION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of FLUARIX QUADRIVALENT
| Product NDC: | 58160-900 |
| Labeler Name: | GlaxoSmithKline Biologicals SA |
| Product Type: | VACCINE |
| FDA Application Number: | BLA125127 |
| Marketing Category: | BLA |
| Start Marketing Date: | 20130701 |
Package Information of FLUARIX QUADRIVALENT
| Package NDC: | 58160-900-52 |
| Package Description: | 10 SYRINGE in 1 CARTON (58160-900-52) > .5 mL in 1 SYRINGE (58160-900-41) |
NDC Information of FLUARIX QUADRIVALENT
| NDC Code | 58160-900-52 |
| Proprietary Name | FLUARIX QUADRIVALENT |
| Package Description | 10 SYRINGE in 1 CARTON (58160-900-52) > .5 mL in 1 SYRINGE (58160-900-41) |
| Product NDC | 58160-900 |
| Product Type Name | VACCINE |
| Non Proprietary Name | influenza virus vaccine |
| Dosage Form Name | SUSPENSION |
| Route Name | INTRAMUSCULAR |
| Start Marketing Date | 20130701 |
| Marketing Category Name | BLA |
| Labeler Name | GlaxoSmithKline Biologicals SA |
| Substance Name | INFLUENZA A VIRUS A/CHRISTCHURCH/16/2010 NIB-74XP (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA A VIRUS A/TEXAS/50/2012 X-223A (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/BRISBANE/60/2008 ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/MASSACHUSETTS/2/2012 BX-51B ANTIGEN (FORMALDEHYDE INACTIVATED) |
| Strength Number | 15; 15; 15; 15 |
| Strength Unit | ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL |
| Pharmaceutical Classes |
